52.85
                                            Biomarin Pharmaceutical Inc Aktie (BMRN) Neueste Nachrichten
BioMarin Pharmaceutical Unleashes VOXZOGO Expansion—Is a Market Breakout Coming? - Smartkarma
Pulmonary Emphysema Market Set to Expand by 2034 with Rising COPD Prevalence and Therapeutic Innovation | DelveInsight - GlobeNewswire Inc.
Will BioMarin Pharmaceutical Inc. (BM8) stock hit analyst forecastsQuarterly Earnings Report & Long-Term Capital Growth Strategies - newser.com
Bernstein lowers BioMarin stock price target to $88 on growth concerns - Investing.com
Using AI based signals to follow BioMarin Pharmaceutical Inc.July 2025 Sentiment & Technical Confirmation Alerts - newser.com
Key resistance and support levels for BioMarin Pharmaceutical Inc.July 2025 News Drivers & Fast Entry Momentum Alerts - newser.com
Eleva Capital SAS Invests $1.29 Million in BioMarin Pharmaceutical Inc. $BMRN - MarketBeat
Is BioMarin Pharmaceutical Inc. (BM8) stock cheap by valuation metricsDollar Strength & Weekly Stock Performance Updates - newser.com
Keybank National Association OH Sells 19,707 Shares of BioMarin Pharmaceutical Inc. $BMRN - MarketBeat
The 5 Most Interesting Analyst Questions From BioMarin Pharmaceutical’s Q3 Earnings Call - TradingView
Can BioMarin Pharmaceutical Inc. stock hit analyst price targets2025 Buyback Activity & Consistent Profit Alerts - newser.com
How to manage a losing position in BioMarin Pharmaceutical Inc.Day Trade & Fast Momentum Entry Tips - newser.com
Exit strategy if you’re trapped in BioMarin Pharmaceutical Inc.July 2025 Fed Impact & Real-Time Market Trend Scan - newser.com
How strong is BioMarin Pharmaceutical Inc. stock balance sheetMarket Growth Summary & Free Fast Gain Swing Trade Alerts - newser.com
BioMarin Pharmaceutical (NASDAQ:BMRN) Rating Lowered to "Hold" at Wall Street Zen - MarketBeat
What is William Blair's Estimate for BMRN Q4 Earnings? - MarketBeat
Fjarde AP Fonden Fourth Swedish National Pension Fund Purchases 14,700 Shares of BioMarin Pharmaceutical Inc. $BMRN - MarketBeat
Can BioMarin Pharmaceutical Inc. (BM8) stock reach $200 price targetOptions Play & Weekly Return Optimization Plans - newser.com
Why BioMarin Pharmaceutical Inc. stock is in analyst buy zoneWeekly Trend Report & Safe Capital Growth Stock Tips - newser.com
Why BioMarin Pharmaceutical Inc. stock is seen as undervaluedJobs Report & Free Technical Pattern Based Buy Signals - newser.com
Morgan Stanley Maintains Buy on BioMarin Pharmaceutical (BMRN) - MSN
BioMarin Pharmaceutical (BMRN): Evaluating Valuation as Shares Recover 3% After Prolonged Downtrend - Sahm
How to monitor BioMarin Pharmaceutical Inc. with trend dashboards2025 Valuation Update & High Yield Stock Recommendations - newser.com
10 Best Beaten Down Growth Stocks to Buy According to Analysts - Insider Monkey
BioMarin Pharmaceutical (NASDAQ:BMRN) Reaches New 12-Month LowWhat's Next? - MarketBeat
Cantor Fitzgerald Has Negative View of BMRN FY2025 Earnings - MarketBeat
How currency fluctuations impact BioMarin Pharmaceutical Inc. stock2025 Technical Overview & Safe Swing Trade Setups - newser.com
How to read the order book for BioMarin Pharmaceutical Inc.Market Activity Report & Daily Profit Focused Stock Screening - newser.com
Sentiment analysis tools applied to BioMarin Pharmaceutical Inc.Global Markets & AI Enhanced Trading Alerts - newser.com
BioMarin Pharmaceutical (BMRN) Announces Financial Results for Q3 2025 - Insider Monkey
13 Stocks to Buy with Exponential Growth Heading into 2026 - Insider Monkey
BioMarin Pharmaceutical Inc. Just Missed Earnings With A Surprise LossHere Are Analysts Latest Forecasts - Yahoo Finance
Earnings Miss: BioMarin Pharmaceutical Inc. Missed EPS And Analysts Are Revising Their Forecasts - simplywall.st
Biomarin Pharmaceutical stock hits 52-week low at 51.52 USD By Investing.com - Investing.com South Africa
After a futile battle, Biomarin will sell the bleeding disorder drug Roctavian - medwatch.com
Biomarin Pharmaceutical stock hits 52-week low at 51.52 USD - Investing.com
Cantor Fitzgerald Issues Negative Forecast for BMRN Earnings - MarketBeat
        In Yahoo öffnen
        |
        In Google öffnen
            |
            In Finviz öffnen
        |
        In MarketWatch öffnen
            |
            Öffnen Sie in EDGAR    
        |
        Offen in Reuters
    
    
                Kapitalisierung:
                 
                  | 
                Volumen (24h):